CD8A and neoplasm: Overall, these results indicate a role of myeloid-ILK in tumour promotion through regulation of the tumour-infiltration of T cells either by restraining tumour-suppressing CD8+ T cells or by enhancing tumour-promoting FOXP3+ T cells.